搜索筛选:
搜索耗时2.9016秒,为你在为你在102,285,761篇论文里面共找到 1 篇相符的论文内容
发布年度:
Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor t
[期刊论文] 作者：Chen-yu Wang,Chang-cheng Sheng,Guang-li Ma,Da Xu,Xiao-qin Liu,Yu-ya Wang,Li Zhang,Chuan-liang Cui,Bing-he,
来源：中国药理学报（英文版） 年份：2021
Camrelizumab,a programmed cell death 1(PD-1)inhibitor,has been approved for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma,nasopharyngeal cancer and non-small cell lung cancer.The aim of this study was to p......
相关搜索：
